Müller N - Search Results

1

Digitized analysis of abnormal hand-motor performance in schizophrenic patients.

Tigges P, Mergl R, Frodl T, Meisenzahl EM, Gallinat J, Schröter A, Riedel M, Müller N, Möller HJ, Hegerl U. Tigges P, et al. Among authors: muller n. Schizophr Res. 2000 Sep 29;45(1-2):133-43. doi: 10.1016/s0920-9964(99)00185-1. Schizophr Res. 2000. PMID: 10978881

2

Cellular immunity in schizophrenic patients before and during neuroleptic treatment.

Müller N, Ackenheil M, Hofschuster E, Mempel W, Eckstein R. Müller N, et al. Psychiatry Res. 1991 May;37(2):147-60. doi: 10.1016/0165-1781(91)90072-w. Psychiatry Res. 1991. PMID: 1678892

3

Immunoglobulin and albumin content of cerebrospinal fluid in schizophrenic patients: relationship to negative symptomatology.

Müller N, Ackenheil M. Müller N, et al. Schizophr Res. 1995 Feb;14(3):223-8. doi: 10.1016/0920-9964(94)00045-a. Schizophr Res. 1995. PMID: 7766533

4

Interleukin-6 is not altered in cerebrospinal fluid of first-degree relatives and patients with Alzheimer's disease.

Hampel H, Schoen D, Schwarz MJ, Kötter HU, Schneider C, Sunderland T, Dukoff R, Levy J, Padberg F, Stübner S, Buch K, Müller N, Möller HJ. Hampel H, et al. Among authors: muller n. Neurosci Lett. 1997 Jun 13;228(3):143-6. doi: 10.1016/s0304-3940(97)00379-0. Neurosci Lett. 1997. PMID: 9218628

5

Saccades in Gilles de la Tourette's syndrome.

Straube A, Mennicken JB, Riedel M, Eggert T, Müller N. Straube A, et al. Among authors: muller n. Mov Disord. 1997 Jul;12(4):536-46. doi: 10.1002/mds.870120410. Mov Disord. 1997. PMID: 9251072

6

Neuroleptic treatment increases soluble IL-2 receptors and decreases soluble IL-6 receptors in schizophrenia.

Müller N, Empl M, Riedel M, Schwarz M, Ackenheil M. Müller N, et al. Eur Arch Psychiatry Clin Neurosci. 1997;247(6):308-13. doi: 10.1007/BF02922260. Eur Arch Psychiatry Clin Neurosci. 1997. PMID: 9477010 Clinical Trial.

7

Lyme disease presenting as Tourette's syndrome.

Riedel M, Straube A, Schwarz MJ, Wilske B, Müller N. Riedel M, et al. Among authors: muller n. Lancet. 1998 Feb 7;351(9100):418-9. doi: 10.1016/S0140-6736(05)78357-4. Lancet. 1998. PMID: 9482302 No abstract available.

8

Increased frequency of CD8 positive gamma/delta T-lymphocytes (CD8+ gamma/delta+) in unmedicated schizophrenic patients: relation to impairment of the blood-brain barrier and HLA-DPA*02011.

Müller N, Schlesinger BC, Hadjamu M, Riedel M, Schwarz M, Ackenheil M, Wank R, Gruber R. Müller N, et al. Schizophr Res. 1998 Jun 22;32(1):69-71. doi: 10.1016/s0920-9964(98)00036-x. Schizophr Res. 1998. PMID: 9690337 No abstract available.

9

[Immunoglobulin therapy in Gilles de la Tourette syndrome].

Müller N, Riedel M, Erfurth A, Möller HJ. Müller N, et al. Nervenarzt. 1997 Nov;68(11):914-6. doi: 10.1007/s001150050216. Nervenarzt. 1997. PMID: 9732736 German.

10

Blood-cerebrospinal fluid barrier impairment as indicator for an immune process in schizophrenia.

Schwarz MJ, Ackenheil M, Riedel M, Müller N. Schwarz MJ, et al. Among authors: muller n. Neurosci Lett. 1998 Sep 11;253(3):201-3. doi: 10.1016/s0304-3940(98)00655-7. Neurosci Lett. 1998. PMID: 9792246

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,478 results

Search Page

Filters